VR Logo

Certara Inc. (CERT) download report


Healthcare | Health Services

Certara Inc. (CERT) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access.

IPO Date: 11-Dec-2020

CEO & Director: Dr. William F. Feehery Ph.D.

Chief Financial Officer: Mr. M. Andrew Schemick

Listing: NASDAQ: CERT

Country: United States

Headquarters: Princeton, NJ

Website: https://www.certara.com

Key Facts

Market cap: $3,530.91 Mln

Revenue (TTM): $300.94 Mln

Earnings (TTM): $-12.11 Mln

Cash: $184.32 Mln

Total Debt: $308.82 Mln

Insider's Holding: 4.28%

Liquidity: Low

52 Week range: $16.18 - 45.48

Shares outstanding: 159,842,000

Stock Performance

Time Period Certara (CERT) S&P BSE Healthcare S&P Small-Cap 600
YTD-22.27-17.04-18.78
1 month5.39-3.24-8.00
3 months2.84-10.55-13.65
1 Year-22.03-15.04-17.19
3 Years--19.036.10
5 Years--8.915.87
10 Years--12.199.84
As on 01-Jul-2022
Year Certara (CERT) S&P Small-Cap 600 S&P BSE Healthcare
2021-15.7225.2720.87